Core Viewpoint - The recent surge in A-share market has led to increased research and adjustments in stock ratings by brokerage analysts, with a focus on various industries including electronics, pharmaceuticals, and machinery [1][3]. Group 1: Brokerage Research Activities - A total of 162 companies have been researched by brokerages since August, with significant representation from the electronics (22 companies), pharmaceuticals (21 companies), and machinery (20 companies) sectors [3]. - The electronics sector has seen the highest engagement, with companies like Baiwei Storage attracting 37 brokerages for research [3]. - The machinery sector is also popular, with companies like Jerry Holdings receiving attention from 41 brokerages [5]. Group 2: Popular Companies Among Analysts - Zhongchong Co. has been the most researched company, attracting 61 brokerages, with a stock price increase of 66% this year [4][6]. - Ninebot and Ganyuan Foods have also garnered significant interest, with 47 and 44 brokerages respectively conducting research [6]. - Jerry Holdings has been a focus for 41 brokerages, with a stock price increase of 26.72% this year [7]. Group 3: Pharmaceutical Sector Insights - The pharmaceutical sector has become a focal point for brokerages, with over 65 reports published since August, indicating strong interest [9]. - Companies like Jiuzhou Pharmaceutical and Sanxin Medical have been highlighted for their international expansion and growth in client acquisition [9][10]. - Jiuzhou Pharmaceutical reported a net profit of 526 million yuan, a year-on-year increase of 10.7% [9]. Group 4: Rating Adjustments - Seven companies have had their stock ratings upgraded since August, including Hai Guang Information, which reported a net profit of 1.201 billion yuan, a 40.78% increase year-on-year [12]. - Huaneng International's rating was also upgraded following a net profit of 9.262 billion yuan, a 24.26% increase [12]. - One company, Fuling Pickled Vegetable, had its rating downgraded due to slower sales recovery and increased cost pressures [13].
券商8月以来调研162家公司,宠物龙头人气最高,创新药受关注
